Home / Cancer and immune system / Amsacrine
ATC L01XX01 · Other Antineoplastic Agents · updated 2 Nov 2026
Amsacrine shortage
As of 2 Nov 2026, Amsacrine has a reported shortage in 1 of the 16 countries we track (Canada), covering 1 product from 1 company.
Is there an Amsacrine shortage?
Yes. As of 2 Nov 2026, Amsacrine is reported short in 1 of the 16 countries we track: Canada. No company has given a return date.
Timeline
Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.
Which companies are short
products short, all countriesCompared with similar medicines
ATC group L01XX · Other Antineoplastic AgentsAffected products
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CA | AMSA PD INJ 50MG/ML (Vial) | ERFA CANADA 2012 INC | 21 Jul 2014 | not given | Manufacturing problem Requirements related to complying with good manufacturing practices |
"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.
Questions
Is there an Amsacrine shortage?
Yes. As of 2 Nov 2026, Amsacrine is reported short in 1 of the 16 countries we track: Canada. No company has given a return date.
When will Amsacrine be back in stock?
No return date has been given; Canada: no date given. These are company estimates reported to each authority.
Why is Amsacrine in short supply?
The most common reason reported is: manufacturing problem. Reasons by product are listed in the table below.
Which companies have Amsacrine shortages?
Erfa 2012.